Maturity onset diabetes mellitus (NIDDM or Type-2 Diabetes mellitus) is one of the most common under-diagnosed problems, with millions of Indians unaware that they are suffering from it. Unfortunately India has ranked No. 1, in December 2006, in diabetic population by International Diabetic Federation.
Dibonil is a result oriented product which is developed for the management of maturity onset diabetes mellitus. It takes care of associated symptoms and delays complications of diabetes thus improves quality of life of diabetics and helps them to get back in their normal life. It can be taken along with anti-hyperglycaemic drugs.